tirzepatide fda news No, the is not taking GLP-1 medications off the market — but the compounded “copycat” versions may be getting a lot harder to access. This is where patient safety, cost, and access all collide., FDA Approves Tirzepatide, A Potential

For example, one source puts intranasal DSIP as more patient-compliance friendly than injections

Over-the-Counter and Prescription Solutions for Semaglutide Constipation If lifestyle changes do not resolve constipation within two to three weeks, osmotic laxatives such as polyethylene glycol (MiraLAX) or magnesium citrate are safe first-line options

Birth control methods fall into four main groups: barrier methods, hormonal methods (including emergency contraception), long-acting reversible contraception (LARC) methods, and sterilization

Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study